Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 18 ABBV Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 17 ABBV AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
May 17 ANIP Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
May 17 ANIP Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
May 17 ABBV Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls
May 17 ABBV AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
May 16 ANIP Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)
May 16 ABBV AbbVie CEO latest heavy hitter to buy in Boca Raton
May 16 ANIP Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 16 ANIP Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
May 15 ABBV AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript
May 15 AGRX Agile Therapeutics Non-GAAP EPS of -$0.63, revenue of $5.7M
May 15 SXTP 60 Degrees Pharmaceuticals reports Q1 results
May 15 AGRX Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15 SXTP 60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
May 15 ANIP FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
May 15 ABBV NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
May 14 ANIP Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
May 14 ABBV AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
May 14 ANIP Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags